Persistence of left atrial thrombus in patients with hypertrophic cardiomyopathy and atrial fibrillation-Reference-Cited by-同舟云学术

Persistence of left atrial thrombus in patients with hypertrophic cardiomyopathy and atrial fibrillation

Published:2023-09-16 Issue: Volume: Page:
ISSN:1572-8595
Container-title:Journal of Interventional Cardiac Electrophysiology
language:en
Short-container-title:J Interv Card Electrophysiol

Author:

Burczak Daniel R.,Scott Christopher G.,Julakanti Raghav R.,Kara Balla Abdalla,Swain William H.,Ismail Khaled,Geske Jeffrey B.,Killu Ammar M.,Deshmukh Abhishek J.,MacIntyre Ciorsti J.,Ommen Steve R.,Nkomo Vuyisile T.,Gersh Bernard J.,Noseworthy Peter A.,Siontis Konstantinos C.

Publisher

Springer Science and Business Media LLC

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Link

https://link.springer.com/content/pdf/10.1007/s10840-023-01642-5.pdf

Reference17 articles.

1. Siontis KC, Geske JB, Ong K, Nishimura RA, Ommen SR, Gersh BJ. Atrial fibrillation in hypertrophic cardiomyopathy: prevalence, clinical correlations, and mortality in a large high-risk population. J Am Heart Assoc. 2014;3: e001002.

2. Rowin EJ, Hausvater A, Link MS, et al. Clinical Profile and Consequences of Atrial Fibrillation in Hypertrophic Cardiomyopathy. Circulation. 2017;136:2420–36.

3. Burczak D, Julakanti R, Kara Balla A, et al. Risk of Left Atrial Thrombus in Patients With Hypertrophic Cardiomyopathy and Atrial Fibrillation. J Am Coll Cardiol. 2023Jul;82(3):278–9.

4. Noseworthy PA, Yao X, Shah ND, Gersh BJ. Stroke and Bleeding Risks in NOAC- and Warfarin-Treated Patients With Hypertrophic Cardiomyopathy and Atrial Fibrillation. J Am Coll Cardiol. 2016;67:3020–1.

5. Dominguez F, Climent V, Zorio E, et al. Direct oral anticoagulants in patients with hypertrophic cardiomyopathy and atrial fibrillation. Int J Cardiol. 2017;248:232–8.